Photo from wikipedia
Hepatic Oncology, BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA; Mount Sinai… Click to show full abstract
Hepatic Oncology, BCLC Hospital Clínic Barcelona, IDIBAPS, University of Barcelona CIBERehd, Barcelona, Spain; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan; Bayer HealthCare Pharmaceuticals, Whippany, NJ, USA; Mount Sinai Liver Cancer Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Catalonia, Spain
Keywords:
sorafenib benefit;
prognostic factors;
corrigendum prognostic;
oncology;
predictors sorafenib;
factors predictors
Journal Title: Journal of hepatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of hepatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!